A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder - Papakostas, G I; Vitolo, OV; Ishak, W W (J Clin Psychiatry, 2012)
et al.